Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Urinary Bladder Neoplasms × Single Person × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 5 Prostatic Neoplasms 2 Lung Neoplasms 2 Urinary Bladder Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Leukemia, Myeloid, Acute 1 Gastroesophageal Adenocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma 1

Interventions

Gemcitabine 132 Cisplatin 96 pembrolizumab 67 Paclitaxel 37 Carboplatin 36 Nivolumab 35 Cystectomy 35 Docetaxel 34 Mitomycin 32 atezolizumab 29 durvalumab 28 Radiotherapy 25 Magnetic Resonance Spectroscopy 25 avelumab 21 Specimen Handling 21 Doxorubicin 20 BCG Vaccine 20 Fluorouracil 18 Cystoscopy 18 enfortumab vedotin 16 Methotrexate 15 Vinblastine 14 Standard of Care 14 Filgrastim 13 vinflunine 12 Ipilimumab 12 Transurethral Resection of Bladder 11 Sunitinib 11 Radiation 11 5-aminolevulinic acid hexyl ester 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03347045 2017-11-20

TPC-RCT

Alberta Health Services, Calgary

Phase NA Unknown

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡